Clinical Trial Comparing Patency and Safety of the Paclitaxel Eluting Covered Metallic Biliary Stent(Niti-S Mira-Cover Biliary Stent ) to the Common Covered Metallic Biliary Stent(Niti-S Biliary Stent)
Paclitaxel covered metal biliary stent(Mira-Cover Biliary Stent) extents their patency rate
comparing to the Common Covered Metallic Biliary Stent(Niti-S Biliary Stent.
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Supportive Care
Accumulative Patency Rate
Dong Ki Lee, Ph.D
Kangnam Severance Hospital
Korea: Food and Drug Administration